Monistrol sur Loire, Nov. 26, 2019
Using passively beating explanted hearts in a simulator, CMI’nov has validated the proper implantation, anchoring of the nitinol rings and the reduction of the mitral annulus. The procedures were successfully completed under visual assessment and echography control. Bernard Pain, President, declared: “This is an important step in the development of Mit’rep. We confirmed that our device, and the braid that is used to reduce the mitral annulus, can be successfully and functionally delivered at the proper location. The next step will be to complete a similar implantation in vivo, which we anticipate in early 2020.”
Mit’rep is a new generation minimally invasive annuloplasty device for the treatment of functional mitral regurgitation. Nitinol anchors delivered transapically are used to position a braid along the mitral ring, which is then used to reduce the mitral valve diameter at will, in real-time under echography.
For additional information, please contact Corinne.email@example.com